Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder
Rapid Cycling Bipolar Disorder (RCBPD), Subjective Illness Experience and Gender
1 other identifier
observational
40
1 country
2
Brief Summary
This study will examine how various factors, such as psychiatric symptoms, gender, quality of life, and attitudes toward medication, affect treatment adherence in individuals with rapid cycling bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2004
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedFebruary 6, 2019
February 1, 2019
2.3 years
September 14, 2005
February 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Subjective Experience of Medication Interview (SEMI)
The Subjective Experience of Medication Interview (SEMI) is a qualitative, semi-structured assessment of subjective experience of mental illness, which requires approximately 60-120 minutes to administer. Illness experience domains assessed include illness attitudes, attributions and behaviors, social relations, treatment history and medication experience, self-medication, quality of life, stigma, culture/ethnicity, and health care logistics. The SEMI has been modified for use in populations with Bipolar Disorder.
Baseline
Secondary Outcomes (7)
Hamilton Depression Rating Scale (HAMD)
Baseline
Clinical Global Impression (CGI)
Baseline
Insight and Treatment Attitudes Questionnaire (ITAQ)
Baseline
Illness Behavior Questionnaire (IBQ)
Baseline
Attitude Towards Mood Stabilizers Questionnaire (AMSQ)
Baseline
- +2 more secondary outcomes
Study Arms (1)
Qualitative Interview
Participants with rapid cycling bipolar disorder (RCBPD)
Eligibility Criteria
The population includes 20 individuals receiving treatment at an academic medical center and 20 individuals seeking treatment at a community mental health clinic.
You may qualify if:
- Clinical diagnosis of rapid cycling variant of bipolar disorder type I; diagnosed 2 to 20 years prior to study entry
- Has experienced an index depressive episode
- Received treatment with medication to stabilize mood for at least 6 months prior to study entry
- Lives in the Northeast Ohio area and is a patient at either Northeast Ohio Health Services or The Mood Disorders Clinic at University Hospitals of Cleveland
You may not qualify if:
- Unable/unwilling to participate in psychiatric interviews
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Northeast Ohio Health Services
Beachwood, Ohio, 44122, United States
University Hospitals of Cleveland
Cleveland, Ohio, 44106, United States
Related Publications (2)
Sajatovic M, Jenkins JH, Cassidy KA, Muzina DJ. Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. J Affect Disord. 2009 Jun;115(3):360-6. doi: 10.1016/j.jad.2008.10.002. Epub 2008 Nov 8.
PMID: 18996600RESULTSajatovic M, Jenkins JH, Safavi R, West JA, Cassidy KA, Meyer WJ, Calabrese JR. Personal and societal construction of illness among individuals with rapid-cycling bipolar disorder: a life-trajectory perspective. Am J Geriatr Psychiatry. 2008 Sep;16(9):718-26. doi: 10.1097/JGP.0b013e3180488346. Epub 2007 Dec 10.
PMID: 18070834RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martha Sajatovic, MD
Case Western Reserve University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry and of Neurology
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 16, 2005
Study Start
July 1, 2004
Primary Completion
November 1, 2006
Study Completion
August 1, 2007
Last Updated
February 6, 2019
Record last verified: 2019-02